StockNews.AI
OGI
StockNews.AI
169 days

Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment

1. Organigram closed the final tranche of C$124.56 million investment from BT DE Investments. 2. This strategic equity investment supports Organigram's growth and operational capability.

2m saved
Insight
Article

FAQ

Why Bullish?

The substantial investment from British American Tobacco signals confidence in Organigram's future. Historical data shows similar investments often lead to positive price movements.

How important is it?

The strategic partnership with BAT indicates a strong endorsement and financial backing, likely enhancing OGI's market position.

Why Long Term?

The investment enhances growth potential, suggesting benefits will manifest over time as strategies unfold.

Related Companies

BTIAPHACRON
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T.

Related News